Showing results (1371-1380 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|May 8, 2020
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 StudyEric X Chen, Derek J Jonker, Jonathan M Loree, et al.
JAMA Oncology|May 30, 2020
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-upHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
JAMA Oncology|May 30, 2020
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell CarcinomaPraful Ravi, Charlene Mantia, Christopher Su, et al.
JAMA Oncology|May 30, 2020
Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017Ankit Agarwal, Andrew Roberts, Stacie B Dusetzina, et al.
JAMA Oncology|June 20, 2020
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US AdultsSusan C Gilchrist, Virginia J Howard, Tomi Akinyemiju, et al.
JAMA Oncology|December 1, 2022
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer TreatmentYuhua Bao, Hao Zhang, Eduardo Bruera, et al.
JAMA Oncology|July 7, 2022
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical TrialHee Kyung Ahn, Sung Hoon Sim, Koung Jin Suh, et al.
JAMA Oncology|January 19, 2023
Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow TransplantAndrew McDonald, Chen Dai, Qingrui Meng, et al.
JAMA Oncology|July 1, 2021
Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung CancerFrederik Bartels, Mona-Marie Wandrey, Annette Aigner, et al.
JAMA Oncology|July 1, 2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeKerstin N Vokinger, Thomas J Hwang, Paola Daniore, et al.
Pageof 162